Caplight Directory>Investors>Decheng Capital>Decheng-capital


Decheng Capital

Decheng Capital

Menlo Park, Californiadechengcapital.com

Overview

Decheng Capital is a global investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence.

Year Founded

2012

AUM

$2B

Portfolio Companies

42

Investments

CompanyDateStageLead
Vivacta Biotechnology (Shanghai) Co., Ltd.Apr 2026Series ALead
Syneron BioMar 2026Series BLead
Syneron BioMar 2026Series BLead
Polares MedicalMar 2026Series CLead
Phrontline BiopharmaNov 2025pre_series_a_plusCo-investor
View all investments

Key People

Dan Zabrowski

Venture Partner

Dayton Misfeldt

Partner

Nick Pliam

Partner

Qiang Xu

Partner

Y. Katherine Xu

Partner

Michael Notaras

Vice President - Biotech Public Equities Venture Capital

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2012
AUM$2B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.